These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11056097)

  • 1. Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: the Heart and Estrogen/Progestin Replacement Study.
    Hsia J; Simon JA; Lin F; Applegate WB; Vogt MT; Hunninghake D; Carr M
    Circulation; 2000 Oct; 102(18):2228-32. PubMed ID: 11056097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
    Hsia J; Criqui MH; Rodabough RJ; Langer RD; Resnick HE; Phillips LS; Allison M; Bonds DE; Masaki K; Caralis P; Kotchen JM;
    Circulation; 2004 Feb; 109(5):620-6. PubMed ID: 14769684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
    JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
    N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
    Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
    Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.
    Toh S; Hernández-Díaz S; Logan R; Rossouw JE; Hernán MA
    Ann Intern Med; 2010 Feb; 152(4):211-7. PubMed ID: 20157135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
    Chlebowski RT; Anderson GL; Gass M; Lane DS; Aragaki AK; Kuller LH; Manson JE; Stefanick ML; Ockene J; Sarto GE; Johnson KC; Wactawski-Wende J; Ravdin PM; Schenken R; Hendrix SL; Rajkovic A; Rohan TE; Yasmeen S; Prentice RL;
    JAMA; 2010 Oct; 304(15):1684-92. PubMed ID: 20959578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.
    Chlebowski RT; Anderson GL; Sarto GE; Haque R; Runowicz CD; Aragaki AK; Thomson CA; Howard BV; Wactawski-Wende J; Chen C; Rohan TE; Simon MS; Reed SD; Manson JE
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26668177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
    Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
    Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
    Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D;
    JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
    Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
    Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.